Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the 43rd Annual J.P. Morgan Healthcare Conference.
宾夕法尼亚州拉德诺，2025年1月2日（全球新闻通讯）-- Certara, Inc.（纳斯达克：CERT），作为模型引导药物开发的全球领导者，今天宣布公司管理层将参加第43届摩根大通医疗保健会议。
Company management will present at 5:15PM PT on Wednesday, January 15th, 2025.
公司管理层将在2025年1月15日星期三太平洋时间下午5:15进行演讲。
A live webcast of the event will be available on Certara's investor relations website at and will be available for replay for at least 30 days thereafter.
该活动的直播网络广播将在Certara的投资者关系网站上提供，并将在之后至少可重播30天。
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
关于Certara
Certara利用生物仿真软件、科技和服务加速药物研发，以转变传统的药物发现和开发方式。它的客户包括来自66个国家的2400多家生物制药公司、学术机构和监管机构。了解更多请访问certara.com。
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
投资者关系联系：
大卫·德彻勒
吉尔马丁集团
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
媒体联系人：
艾莉莎·霍罗维茨
certara@pancomm.com
